These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36011408)

  • 1. Genetic Variants Associated with Elevated Plasma Ceramides in Individuals with Metabolic Syndrome.
    Lee S; Kim SA; Kim Y; Kim J; Hong G; Hong J; Choi K; Eom CS; Baik S; Lee MK; Lee KR
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for quantifying hepatic and intestinal ceramides on mice by UPLC-MS/MS.
    Ge K; Zheng D; Wang J; Jia W; Zhao A
    Anal Biochem; 2023 Jan; 661():114982. PubMed ID: 36375519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome.
    Warshauer JT; Lopez X; Gordillo R; Hicks J; Holland WL; Anuwe E; Blankfard MB; Scherer PE; Lingvay I
    Diabetes Metab Res Rev; 2015 Oct; 31(7):734-44. PubMed ID: 25959529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans.
    Chung JO; Koutsari C; Blachnio-Zabielska AU; Hames KC; Jensen MD
    Diabetes; 2017 Aug; 66(8):2082-2091. PubMed ID: 28483801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance.
    Haus JM; Kashyap SR; Kasumov T; Zhang R; Kelly KR; Defronzo RA; Kirwan JP
    Diabetes; 2009 Feb; 58(2):337-43. PubMed ID: 19008343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographic and clinical variables affecting mid- to late-life trajectories of plasma ceramide and dihydroceramide species.
    Mielke MM; Bandaru VV; Han D; An Y; Resnick SM; Ferrucci L; Haughey NJ
    Aging Cell; 2015 Dec; 14(6):1014-23. PubMed ID: 26193443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome?
    Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma ceramides are elevated in female children and adolescents with type 2 diabetes.
    Lopez X; Goldfine AB; Holland WL; Gordillo R; Scherer PE
    J Pediatr Endocrinol Metab; 2013; 26(9-10):995-8. PubMed ID: 23612696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceramide metabolism in mouse tissue.
    Schiffmann S; Birod K; Männich J; Eberle M; Wegner MS; Wanger R; Hartmann D; Ferreiros N; Geisslinger G; Grösch S
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1886-94. PubMed ID: 23792024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma C18:0-ceramide is a novel potential biomarker for disease severity in myasthenia gravis.
    Zhang Z; Huang X; Du X; Wang Z; Wang Y; Xu M; Chen X; Yao Q; Yan L; Zhang Y
    J Neurochem; 2023 Jun; 165(6):907-919. PubMed ID: 37158660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes.
    Denimal D; Bergas V; Pais-de-Barros JP; Simoneau I; Demizieux L; Passilly-Degrace P; Bouillet B; Petit JM; Rouland A; Bataille A; Duvillard L; Vergès B
    Cardiovasc Diabetol; 2023 May; 22(1):104. PubMed ID: 37143040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Danhe granule ameliorates nonalcoholic steatohepatitis and fibrosis in rats by inhibiting ceramide de novo synthesis related to CerS6 and CerK.
    Zhu M; Jia Z; Yan X; Liu L; Fang C; Feng M; Dai Y; Zhang Y; Wu H; Huang B; Li Y; Liu J; Xiao H
    J Ethnopharmacol; 2022 Sep; 295():115427. PubMed ID: 35654350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
    Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
    Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance induced by de novo pathway-generated C16-ceramide is associated with type 2 diabetes in an obese population.
    Chathoth S; Ismail MH; Alghamdi HM; Zakaria HM; Hassan KA; Alshomimi S; Vatte C; Cyrus C; Alsaif HS; Mostafa A; Shaaban H; Al Ali A
    Lipids Health Dis; 2022 Feb; 21(1):24. PubMed ID: 35184720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between plasma ceramides and mortality in patients with coronary artery disease.
    Li Q; Wang X; Pang J; Zhang Y; Zhang H; Xu Z; Chen Q; Ling W
    Atherosclerosis; 2020 Dec; 314():77-83. PubMed ID: 32980131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-LC-MS/MS for the quantitation of ceramides in mice cerebrospinal fluid using minimal sample volume.
    Thomas D; Eberle M; Schiffmann S; Zhang DD; Geisslinger G; Ferreirós N
    Talanta; 2013 Nov; 116():912-8. PubMed ID: 24148494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of LC-MS/MS method for determination of very long acyl chain (C22:0 and C24:0) ceramides in human plasma.
    Jiang H; Hsu FF; Farmer MS; Peterson LR; Schaffer JE; Ory DS; Jiang X
    Anal Bioanal Chem; 2013 Sep; 405(23):7357-65. PubMed ID: 23857140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.
    Bergman BC; Brozinick JT; Strauss A; Bacon S; Kerege A; Bui HH; Sanders P; Siddall P; Kuo MS; Perreault L
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E398-408. PubMed ID: 26126684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long and Very-Long-Chain Ceramides Correlate with A More Aggressive Behavior in Skull Base Chordoma Patients.
    La Corte E; Dei Cas M; Raggi A; Patanè M; Broggi M; Schiavolin S; Calatozzolo C; Pollo B; Pipolo C; Bruzzone MG; Campisi G; Paroni R; Ghidoni R; Ferroli P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An exploratory study of plasma ceramides in comorbidities in Down syndrome.
    Worley G; Byeon SK; Smith PB; Hart SJ; Young SP; Pandey A; Kishnani PS
    Am J Med Genet A; 2023 Sep; 191(9):2300-2311. PubMed ID: 37340831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.